|
LRRC40 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.90249999976189E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.37889999979524E-07 |
| Normal-vs-Stage2 |
1.484430E-02 |
| Normal-vs-Stage3 |
2.813300E-04 |
| Normal-vs-Stage4 |
2.301800E-01 |
| Stage1-vs-Stage2 |
6.942400E-01 |
| Stage1-vs-Stage3 |
9.228800E-01 |
| Stage1-vs-Stage4 |
5.011000E-01 |
| Stage2-vs-Stage3 |
6.611400E-01 |
| Stage2-vs-Stage4 |
7.533000E-01 |
| Stage3-vs-Stage4 |
4.833400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.67360000033779E-07 |
| Normal-vs-AfricanAmerican |
1.94797999999441E-05 |
| Normal-vs-Asian |
5.918800E-03 |
| Caucasian-vs-AfricanAmerican |
7.392200E-01 |
| Caucasian-vs-Asian |
7.927800E-01 |
| AfricanAmerican-vs-Asian |
8.769000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.67040000007302E-08 |
| Normal-vs-Female |
1.743040E-03 |
| Male-vs-Female |
1.012600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.428780E-04 |
| Normal-vs-Extreme_Weight |
4.96209999756303E-08 |
| Normal-vs-Obese |
1.841090E-04 |
| Normal-vs-Extreme_Obese |
1.466180E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.008400E-01 |
| Normal_Weight-vs-Obese |
7.333200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.257400E-01 |
| Extreme_Weight-vs-Obese |
3.256800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.851200E-01 |
| Obese-vs-Extreme_Obese |
7.776200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.604600E-03 |
| Normal-vs-Age(41-60Yrs) |
9.83679999999598E-05 |
| Normal-vs-Age(61-80Yrs) |
4.17519999684757E-08 |
| Normal-vs-Age(81-100Yrs) |
2.819500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.215600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.669200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.406000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.785900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.110800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.583400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.67509999982052E-07 |
| Normal-VS-Type2 PRCC |
7.776500E-04 |
| Normal-VS-KIRP CIMP |
3.60130000000014E-05 |
| Normal-VS-Unclassified PRCC |
6.702800E-03 |
| Type1 PRCC-VS-Type2 PRCC |
6.725200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.961200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.911800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.561000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.497600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.761780E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.40039999999109E-06 |
| Normal-vs-N1 |
3.625700E-02 |
| Normal-vs-N2 |
3.307000E-01 |
| N0-vs-N1 |
2.680800E-01 |
| N0-vs-N2 |
8.049200E-01 |
| N1-vs-N2 |
5.321200E-01 |
|
|
